Literature DB >> 2818185

Secondary biliary cirrhosis. A limiting factor in the treatment of hepatolithiasis.

K S Jeng1, S C Shih, H J Chiang, B F Chen.   

Abstract

To investigate whether the coexistence of secondary biliary cirrhosis plays a limiting role in the treatment of hepatolithiasis, we retrospectively compared the clinical course and results of stone treatment in 30 patients with secondary biliary cirrhosis (8 in Child's class A and 22 in Child's class B) (group 1) and 240 patients with noncirrhotic biliary calculi (group 2). The hospital mortality, morbidity of treatment, mortality of treatment, and the percentage of treatment failure in group 1 were 20%, 40%, 6.7%, and 16.7%, respectively. Those in group 2 were 8%, 10%, 3.8%, and 10%, respectively. The modes of treatment for stone removal included surgery with postoperative cholangioscopy and percutaneous transhepatic cholangioscopy. There was a statistically significant difference between these two groups in the hospital mortality and the morbidity of treatment. We conclude that hepatolithiasis and biliary stricture should be treated early, before the development of secondary biliary cirrhosis. However, even after cirrhosis occurs, aggressive treatment does not increase the mortality of treatment or the treatment failure rate.

Entities:  

Mesh:

Year:  1989        PMID: 2818185     DOI: 10.1001/archsurg.1989.01410110059012

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  4 in total

1.  Dilatation of intrahepatic biliary strictures in patients with hepatolithiasis.

Authors:  K S Jeng; F S Yang; I Ohta; H J Chiang
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  Recurrent pyogenic cholangitis.

Authors:  Tu Nguyen; Anthony Powell; Tami Daugherty
Journal:  Dig Dis Sci       Date:  2009-08-11       Impact factor: 3.199

3.  A proposed severity classification system for hepatolithiasis based on an analysis of prognostic factors in a Japanese patient cohort.

Authors:  Yutaka Suzuki; Toshiyuki Mori; Masaaki Yokoyama; Sangchul Kim; Hirokazu Momose; Ryota Matsuki; Masaharu Kogure; Nobutsugu Abe; Hiroyuki Isayama; Takahiro Nakazawa; Kenji Notohara; Atsushi Tanaka; Toshio Tsuyuguchi; Susumu Tazuma; Hajime Takikawa; Masanori Sugiyama
Journal:  J Gastroenterol       Date:  2017-11-08       Impact factor: 7.527

4.  Ductal dilatation and stenting for residual hepatolithiasis: a promising treatment strategy.

Authors:  S M Sheen-Chen; Y F Cheng; F C Chen; F F Chou; T Y Lee
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.